Literature DB >> 12090385

Behavioral medicine approaches to somatoform disorders.

Karl J Looper1, Laurence J Kirmayer.   

Abstract

This article reviews the research evidence for the efficacy of cognitive-behavioral therapy (CBT) for somatoform disorders. Randomized controlled studies support the efficacy of individual CBT for the treatment of hypochondriasis, body dysmorphic disorder (BDD), and undifferentiated somatoform disorders including medically unexplained symptoms, chronic fatigue syndrome, and noncardiac chest pain, and group CBT for the treatment of BDD and somatization disorder. On the basis of this review of the existing research and a theoretical model of the processes involved in somatoform disorders, the authors offer suggestions for future research and effective treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12090385

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  21 in total

Review 1.  The relevance of health anxiety to chronic pain: research findings and recommendations for assessment and treatment.

Authors:  Heather D Hadjistavropoulos; Thomas Hadjistavropoulos
Journal:  Curr Pain Headache Rep       Date:  2003-04

Review 2.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

3.  Body awareness: differentiating between sensitivity to and monitoring of bodily signals.

Authors:  Karni Ginzburg; Noga Tsur; Ayelet Barak-Nahum; Ruth Defrin
Journal:  J Behav Med       Date:  2013-04-30

4.  The treatment of patients with medically unexplained symptoms in primary care: a review of the literature.

Authors:  Todd M Edwards; Anthony Stern; David D Clarke; Gabriel Ivbijaro; L Michelle Kasney
Journal:  Ment Health Fam Med       Date:  2010-12

5.  RCT of a care manager intervention for major depression in primary care: 2-year costs for patients with physical vs psychological complaints.

Authors:  L Miriam Dickinson; Kathryn Rost; Paul A Nutting; Carl E Elliott; Robert D Keeley; Harold Pincus
Journal:  Ann Fam Med       Date:  2005 Jan-Feb       Impact factor: 5.166

6.  The Heterogeneity of Illness Behaviors in Patients with Medically Unexplained Physical Symptoms.

Authors:  Frauke Dorothee Weiss; Winfried Rief; Alexandra Martin; Elisabeth Rauh; Maria Kleinstäuber
Journal:  Int J Behav Med       Date:  2016-06

7.  Effectiveness of a time-limited cognitive behavior therapy type intervention among primary care patients with medically unexplained symptoms.

Authors:  Javier I Escobar; Michael A Gara; Angelica M Diaz-Martinez; Alejandro Interian; Melissa Warman; Lesley A Allen; Robert L Woolfolk; Eric Jahn; Denise Rodgers
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

8.  Pain catastrophizing in patients with noncardiac chest pain: relationships with pain, anxiety, and disability.

Authors:  Rebecca A Shelby; Tamara J Somers; Francis J Keefe; Susan G Silva; Daphne C McKee; Lilin She; Sandra J Waters; Indira Varia; Yelena B Riordan; Verena M Knowles; Michael Blazing; James A Blumenthal; Paige Johnson
Journal:  Psychosom Med       Date:  2009-09-08       Impact factor: 4.312

9.  Somatization increases disability independent of comorbidity.

Authors:  Ashley M Harris; E John Orav; David W Bates; Arthur J Barsky
Journal:  J Gen Intern Med       Date:  2008-11-25       Impact factor: 5.128

10.  The effectiveness of a training for patients with unexplained physical symptoms: protocol of a cognitive behavioral group training and randomized controlled trial.

Authors:  Lyonne N L Zonneveld; Adriaan van 't Spijker; Jan Passchier; Jan J van Busschbach; Hugo J Duivenvoorden
Journal:  BMC Public Health       Date:  2009-07-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.